The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gagne, K.
Right arrow Articles by Soulillou, J.-P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gagne, K.
Right arrow Articles by Soulillou, J.-P.
The Journal of Immunology, 2000, 164: 1553-1563.
Copyright © 2000 by The American Association of Immunologists

Highly Altered Vß Repertoire of T Cells Infiltrating Long-Term Rejected Kidney Allografts1

Katia Gagne*,{dagger}, Sophie Brouard*,{ddagger}, Magali Giral*, Fabien Sebille*, Anne Moreau§, Marina Guillet*, Jean-Denis Bignon{dagger}, Berthe-Marie Imbert, Maria-Cristina Cuturi* and Jean-Paul Soulillou2,*

* Institut National de la Santé et de la Recherche Médicale, Unité 437, "Immunointervention dans les Allo et Xénotransplantations" and Institut de Transplantation et de Recherche en Transplantation, Centre Hospitalier Universitaire Hotel Dieu, Nantes, France; {dagger} Etablissement de Transfusion Sanguine, Nantes, France; {ddagger} Harvard Medical School, Beth Israel, Deaconess Medical Center, Boston, MA 02215; § Service d’Anatomopathologie, Centre Hospitalier Universitaire Hotel Dieu, Nantes, France; and Service de Virologie, Institut de Biologie, Nantes, France

Chronic rejection represents a major cause of long-term kidney graft loss. T cells that are predominant in long-term rejected kidney allografts (35 ± 10% of area infiltrate) may thus be instrumental in this phenomenom, which is likely to be dependant on the indirect pathway of allorecognition only. We have analyzed the variations in T cell repertoire usage of the Vß chain at the complementary determining region 3 (CDR3) level in 18 human kidney grafts lost due to chronic rejection. We observed a strongly biased intragraft TCR Vß usage for the majority of Vß families and also a very high percentage (55%) of Vß families exhibiting common and oligoclonal Vß-Cß rearrangements in the grafts of patients with chronic rejection associated with superimposed histologically acute lesions. Furthermore, Vß8 and Vß23 families exhibited common and oligoclonal Vß-Jß rearrangements in 4 of 18 patients (22%). Several CDR3 amino acid sequences were found for the common and oligoclonal Vß8-Jß1.4 rearrangement. Quantitative PCR showed that biased Vß transcripts were also overexpressed in chronically rejected kidneys with superimposed acute lesions. In contrast, T lymphocytes infiltrating rejected allografts with chronic rejection only showed an unaltered Gaussian-type CDR3 length distribution. This pattern suggests that late graft failure associated with histological lesions restricted to Banff-defined chronic rejection does not involve T cell-mediated injury. Thus, our observation suggests that a limited number of determinants stimulates the recipient immune system in long-term allograft failure. The possibility of a local response against viral or parenchymatous cell-derived determinants is discussed.




This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Guillonneau, C. Seveno, A.-S. Dugast, X.-L. Li, K. Renaudin, F. Haspot, C. Usal, J. Veziers, I. Anegon, and B. Vanhove
Anti-CD28 Antibodies Modify Regulatory Mechanisms and Reinforce Tolerance in CD40Ig-Treated Heart Allograft Recipients
J. Immunol., December 15, 2007; 179(12): 8164 - 8171.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
G. Boulday, J. Ashton-Chess, P. Bernard, G. Karam, H. Vie, A. Moreau, D. Minault, K. Lorre, J.-P. Soulillou, and G. Blancho
Association of rapamycin and co-stimulation blockade using anti-B7 antibodies in renal allotransplantation in baboons
Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1752 - 1760.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D.-A. Laplaud, C. Ruiz, S. Wiertlewski, S. Brouard, L. Berthelot, M. Guillet, B. Melchior, N. Degauque, G. Edan, P. Brachet, et al.
Blood T-cell receptor {beta} chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution
Brain, May 1, 2004; 127(5): 981 - 995.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
E Hodges, M T Krishna, C Pickard, and J L Smith
Diagnostic role of tests for T cell receptor (TCR) genes
J. Clin. Pathol., January 1, 2003; 56(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Guillet, S. Brouard, K. Gagne, F. Sebille, M.-C. Cuturi, M.-A. Delsuc, and J.-P. Soulillou
Different Qualitative and Quantitative Regulation of V{beta} TCR Transcripts During Early Acute Allograft Rejection and Tolerance Induction
J. Immunol., May 15, 2002; 168(10): 5088 - 5095.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Baron, I. McMorrow, D. H Sachs, and C. LeGuern
Persistence of Dominant T Cell Clones in Accepted Solid Organ Transplants
J. Immunol., October 15, 2001; 167(8): 4154 - 4160.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Sebille, K. Gagne, M. Guillet, N. Degauque, A. Pallier, S. Brouard, B. Vanhove, M.-A. Delsuc, and J.-P. Soulillou
Direct Recognition of Foreign MHC Determinants by Naive T Cells Mobilizes Specific V{beta} Families Without Skewing of the Complementarity-Determining Region 3 Length Distribution
J. Immunol., September 15, 2001; 167(6): 3082 - 3088.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Boulday, S. Coupel, F. Coulon, J.-P. Soulillou, and B. Charreau
Antigraft Antibody-Mediated Expression of Metalloproteinases on Endothelial Cells : Differential Expression of TIMP-1 and ADAM-10 Depends on Antibody Specificity and Isotype
Circ. Res., March 2, 2001; 88(4): 430 - 437.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.